dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 21, 2026

Does Amazon's Andy Jassy Know Something Wall Street Doesn't? He Just Made a Game-Changing AI Prediction -- and It's Excellent News for Investors.

View original at nasdaq.com
Does Amazon's Andy Jassy Know Something Wall Street Doesn't? He Just Made a Game-Changing AI Prediction -- and It's Excellent News for Investors…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • We have very clear and significant demand signals for AI services

    60% confidence
  • Amazon is generating revenue from new capacity as soon as it becomes available

    60% confidence
  • The 10 best stocks for investors to buy now could produce monster returns, but Amazon wasn't one of them

    60% confidence
  • Amazon is able to monetize new capacity instantly as it becomes available

    60% confidence
  • Stock Advisor's total average return is 911%, a market-crushing outperformance compared to 186% for the S&P 500

    60% confidence
  • AI may help push AWS to $600 billion in annual revenue within a decade, nearly double his earlier forecast

    60% confidence
  • Amazon is not spending $200 billion in capex just hoping AI will be big, but based on clear demand

    60% confidence

Data points we hold from this source

Amazon Web Services · operating income contribution57 percent
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,995
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,995 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Does Amazon's Andy Jassy Know Something Wall Street Doesn't? He Just Made a Game-Changing AI Prediction -- and It's Excellent News for Investors.: Source | Via News | fr.via.news